An investigation by Fujiwara et al. [37] showed that oral administration of tomatidine to apoE-deficient mice significantly reduced levels of serum cholesterol, LDL-cholesterol, and atherosclerosis lesions by suppressing acyl-CoA: cholesterol acyl-transferase (ACAT) activity. The gene discussed is APOE; the disease is atherosclerosis.